| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AMICUS THERAPEUTICS INC | 2,824,185 | 23,497,000 | 15.92% | ||
| 2 | TARO PHARMACEUTICAL INDS LTD | 83,800 | 12,418,000 | 8.41% | ||
| 3 | Receptos Inc | 87,500 | 10,720,000 | 7.26% | ||
| 4 | PERNIX THERAPEUTICS HLDGS IN | 1,134,578 | 10,654,000 | 7.22% | ||
| 5 | AGENUS INC | 2,638,071 | 10,473,000 | 7.10% | ||
| 6 | SORRENTO THERAPEUTICS INC COM NEW | 910,100 | 9,165,000 | 6.21% | ||
| 7 | EMERGENT BIOSOLUTIONS INC COM | 330,635 | 9,003,000 | 6.10% | ||
| 8 | MACROGENICS INC | 162,500 | 5,699,000 | 3.86% | ||
| 9 | ONCOTHYREON INC COM N/C EFF 6/ | 2,991,636 | 5,684,000 | 3.85% | ||
| 10 | BELLICUM PHARMACEUTICALS INC COM | 220,000 | 5,069,000 | 3.43% | ||
| 11 | LA JOLLA PHARMACEUTICAL CO | 246,499 | 4,548,000 | 3.08% | ||
| 12 | IGI LABS INC | 462,342 | 4,069,000 | 2.76% | ||
| 13 | CELGENE CORP | 150,000 | 3,924,000 | 2.66% | Call | |
| 14 | Arrowhead Pharma Inc | 525,000 | 3,875,000 | 2.63% | ||
| 15 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 214,805 | 3,680,000 | 2.49% | ||
| 16 | IGNYTA INC COM | 521,233 | 3,570,000 | 2.42% | ||
| 17 | ALIMERA SCIENCES INC | 674,593 | 3,389,000 | 2.30% | ||
| 18 | DYNAVAX TECHNOLOGIES CORP | 199,332 | 3,361,000 | 2.28% | ||
| 19 | VERICEL CORP | 1,058,820 | 3,219,000 | 2.18% | ||
| 20 | Exelexis | 4,250,000 | 2,398,000 | 1.62% | PRN | |
| 21 | BIOLASE INC | 784,500 | 2,063,000 | 1.40% | ||
| 22 | NOVAVAX INC COM | 300,000 | 1,779,000 | 1.21% | ||
| 23 | CATALYST PHARMACEUTICALS INC | 550,670 | 1,635,000 | 1.11% | ||
| 24 | Innocoll | 225,000 | 1,335,000 | 0.90% | ||
| 25 | FORWARD PHARMA A/S | 50,000 | 1,042,000 | 0.71% | ||
| 26 | HERON THERAPEUTICS INC | 65,900 | 663,000 | 0.45% | ||
| 27 | BIOTA PHARMACEUTIALS INC COM | 258,586 | 579,000 | 0.39% | ||
| 28 | Receptos Inc | 20,000 | 82,000 | 0.06% | Put | |
| 29 | CUBIST PHARMACEUTICALS INC | 141,688 | 6,000 | 0.00% | ||
| 30 | EXACT SCIENCES CORP | 9,600 | 4,000 | 0.00% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-008848, filed 2015.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
